Your browser doesn't support javascript.
loading
Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
Lee, Jun Sung; Kanai, Kazuaki; Suzuki, Mari; Kim, Woojin S; Yoo, Han Soo; Fu, YuHong; Kim, Dong-Kyu; Jung, Byung Chul; Choi, Minsun; Oh, Kyu Won; Li, Yuanzhe; Nakatani, Mitsuyoshi; Nakazato, Tomoko; Sekimoto, Satoko; Funayama, Manabu; Yoshino, Hiroyo; Kubo, Shin-Ichiro; Nishioka, Kenya; Sakai, Ryusuke; Ueyama, Morio; Mochizuki, Hideki; Lee, He-Jin; Sardi, Sergio Pablo; Halliday, Glenda M; Nagai, Yoshitaka; Lee, Phil Hyu; Hattori, Nobutaka; Lee, Seung-Jae.
Afiliação
  • Lee JS; Department of Biomedical Sciences, Neuroscience Research Institute, and Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Kanai K; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Suzuki M; Diabetic Neuropathy Project, Department of Sensory and Motor Systems, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Kim WS; Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Yoo HS; Brain and Mind Centre, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
  • Fu Y; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Kim DK; Brain and Mind Centre, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
  • Jung BC; Department of Biomedical Sciences, Neuroscience Research Institute, and Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Choi M; Department of Biomedical Sciences, Neuroscience Research Institute, and Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Oh KW; Department of Biomedical Sciences, Neuroscience Research Institute, and Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Li Y; Department of Biomedical Sciences, Neuroscience Research Institute, and Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Nakatani M; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Nakazato T; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Sekimoto S; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Funayama M; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Yoshino H; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Kubo SI; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Nishioka K; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Sakai R; Department of Neurology, Juntendo University, School of Medicine, Tokyo 113-8421, Japan.
  • Ueyama M; Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Mochizuki H; Department of Neurology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Lee HJ; Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Sardi SP; Department of Neurology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Halliday GM; Departmen of Anatomy, School of Medicine, Konkuk University, Seoul, Korea.
  • Nagai Y; Genzyme, a Sanofi Company, Framingham, Massachusetts, USA.
  • Lee PH; Brain and Mind Centre, Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
  • Hattori N; Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Lee SJ; Department of Neurology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Brain ; 142(9): 2845-2859, 2019 09 01.
Article em En | MEDLINE | ID: mdl-31312839

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Cerebrosídeo Sulfatase / Mutação Puntual / Chaperonas Moleculares / Mutação de Sentido Incorreto / Alfa-Sinucleína Tipo de estudo: Etiology_studies Idioma: En Revista: Brain Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Cerebrosídeo Sulfatase / Mutação Puntual / Chaperonas Moleculares / Mutação de Sentido Incorreto / Alfa-Sinucleína Tipo de estudo: Etiology_studies Idioma: En Revista: Brain Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido